EuroGCT, the European Consortium for Communicating Gene and Cell Therapy Information, is dedicated to bridging the gap between cutting-edge scientific research and patient care. With a robust partnership comprising 47 organizations across Europe, EuroGCT aims to provide reliable, accessible information on the applications and implications of gene and cell-based therapies. Their work focuses on educating patients, healthcare professionals, and the general public about the scientific, legal, ethical, and societal dimensions of these advanced therapies.

EuroGCT offers an array of educational resources, research pathways, and a directory of key stakeholders in the gene and cell therapy field. Their commitment extends to enhancing patient involvement and engagement while maintaining close collaboration with regulatory bodies, scientists, and the community. Through comprehensive resources developed by experts, EuroGCT equips users with knowledge about ongoing clinical trials, approved medicines, and emerging therapeutic innovations for various conditions, including cancer, genetic disorders, and neurological diseases. By fostering informed conversations, EuroGCT supports the responsible development and application of transformative therapies that hold the potential to improve countless lives.